Richline Pharma Ltd - Company Profile

It is a pharma public limited company based in Hyderabad, Telangana, India, established in 1992.
1992 Hyderabad, Telangana, India Active
Last Updated:
Access Report
About Richline Pharma Ltd

Richline Pharma Ltd, a active public limited company, was established on 30 September 1992 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24239TG1992PLC014809. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹4.18 Cr.

It upholds a active non-compliant status. Its leadership includes Subba Rao Yarapotina (Director), Vijay Kumar Desa (Director), Yerapotina Sri Ramesh Babu (Director). It holds ₹1.75 Cr open charges and no settled loans. Its latest AGM occurred on 31 December 2020, with the balance sheet filed on 31 March 2020. It is based at 8-3-977/9/3,Srinivasa Apts. Srinagar Colony,, Hyderabad, Telangana, 500073.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239TG1992PLC014809

  • Registration Number

    014809

  • Incorporation Date

    30 September 1992

  • Authorized Capital

    ₹5.00 Cr

  • Paid-Up Capital

    ₹4.18 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 5.00 Cr
  • Paid Up Capital ₹ 4.18 Cr
  • Company Age 33 Year, 7 Months
  • Last Filing with ROC 31 Mar 2020
  • Open Charges ₹ 1.75 Cr
Company report

Richline Pharma Ltd

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Richline Pharma Ltd — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Richline Pharma Ltd?
Current Directors
Name Designation Appointment Date Status
Subba Rao Yarapotina Director 30 Sep 1992 Current
Vijay Kumar Desa Director 17 Jan 2007 Current
Yerapotina Sri Ramesh Babu Director 30 Sep 1992 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Richline Pharma.

Enhance accessibility to Richline Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Richline Pharma revenue growth over time
Richline Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Richline Pharma?

Unlock access to Richline Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹17,500,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Canara Bank : 1.75 Cr
Latest Charge Details
Date Lender Amount Status
04 Jan 1996 Canara Bank ₹2.50 M Open
24 Oct 1995 Canara Bank ₹1.50 M Open
05 Oct 1995 Canara Bank ₹2.50 M Open
24 Aug 1994 Canara Bank ₹1.10 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Richline Pharma?

Unlock and access historical data on people associated with Richline Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Richline Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Richline Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Richline Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Richline Pharma Ltd last Annual general meeting of members was held on 31 Dec 2020 as per latest MCA records. was documented.

  • Balance Sheet

    Progress on Richline Pharma Ltd has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Hyderabad. was documented.

  • Director Appointment

    Progress on Vijay Kumar Desa was appointed as a Director was appointed as a Director on 17 Jan 2007 & has been associated with this company since 19 years 4 months . was documented.

  • Charges

    A charge with Canara Bank amounted to Rs. 0.25 Cr with Charge ID 90135544 was registered on 04 Jan 1996. was recorded as a recent event.

  • Charges

    Progress on A charge with Canara Bank amounted to Rs. 0.15 Cr with Charge ID 90135519 was registered on 24 Oct 1995. was documented.

  • Charges

    Progress on A charge with Canara Bank amounted to Rs. 0.25 Cr with Charge ID 90135515 was registered on 05 Oct 1995. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Richline Pharma Ltd?

The CIN of Richline Pharma Ltd is U24239TG1992PLC014809.

Where is Richline Pharma Ltd headquartered?

Richline Pharma Ltd is headquartered at 8-3-977/9/3,Srinivasa Apts. Srinagar Colony,, Hyderabad, Telangana, 500073.

When was Richline Pharma Ltd incorporated?

Richline Pharma Ltd was incorporated on 30 September 1992.

Who are the current directors of Richline Pharma Ltd?

The current directors of Richline Pharma Ltd are

What is the primary industry of Richline Pharma Ltd?

The primary industry of Richline Pharma Ltd is Pharma.

Is Richline Pharma Ltd a listed company?

Richline Pharma Ltd is unlisted.

What is the capital structure of Richline Pharma Ltd?

The authorized capital of Richline Pharma Ltd is ₹5.00 Cr, and the paid-up capital is ₹4.18 Cr.

What is the compliance status of Richline Pharma Ltd?

The compliance status of Richline Pharma Ltd is Active Non-Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available